On September 8, 2020, Bruce Gellin, MD, MPH, president of Global Immunization at the Sabin Vaccine Institute (Sabin), participated in a panel titled, “The Science of Vaccine Confidence,” as part of the 2020 Virtual National Health Research Forum hosted by

This blog post is part of Sabin’s Vaccine IQ: Intro to Vaccine Research & Development series, in which experts from Sabin’s Vaccine R&D team give an introduction to how vaccines are made, explaining the stages of research, development and testing vaccine candidates must go th

This blog post is part of Sabin’s Pivoting in a Pandemic series, which captures stories of extraordinary leaders who are adapting to advance research and public health in the midst of the COVID-19 pandemic.

This blog post is part of Sabin’s Pivoting in a Pandemic series, which captures stories of extraordinary leaders who are adapting to advance research and protecting public health in the midst of COVID-19.

On Dr. Albert B. Sabin’s birthday, his legacy is a reminder that vaccination and health equity go hand-in-hand.

Most vaccination programs focus on protecting children, even though the major burden of vaccine-preventable diseases is in adults.

Professor Gordon Dougan Receives the 2020 Albert B. Sabin Gold Medal; Sabin Vaccine Institute’s New Rising Star Award Presented to Dr. Katherine E. Gallagher

Sabin today announced that it has awarded its annual Albert B. Sabin Gold Medal to Gordon Dougan, FRS, professor in the Department of Medicine and the Cambridge Institute for Therapeutic Immunology and Infectious Disease at the University of Cambridge. Sabin also presented the inaugural Rising Star Award to Katherine E. Gallagher, MSc, PhD, assistant professor of epidemiology at the London School of Hygiene and Tropical Medicine.

Vaccines are one of the greatest achievements in modern medical history. More lives have been saved thanks to vaccines than any other medical advance in recent years.

Sabin's President of Global Immunization Dr. Bruce Gellin Testifies at House Briefing on Approval Processes for Safe, Effective COVID-19 Vaccine

Bruce Gellin, M.D., M.P.H., president of Global Immunization at the Sabin Vaccine Institute (Sabin) and former Deputy Assistant Secretary for Health and Director of the National Vaccine Program Office at the U.S. Department of Health and Human Services (HHS), testified on July, 14, 2020, at the House Subcommittee on Economic and Consumer Policy’s briefing entitled “Guardrails to Ensure a Safe and Effective COVID-19 Vaccine.”

Pages